Identification of the Pathogenetic Mechanisms Underlying Squamous Cell Carcinomas
Recruiting · NCT06236464 · Observational (researchers observe without assigning treatment)
View the official record on ClinicalTrials.gov →Interventions studied
Multiparameter analysis of each sample
What this trial is about
This is a multicentric, retrospective, and prospective biomarker study.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patients aged ≥ 18 years, candidates for surgical treatment for squamous cell carcinoma of the anus, uterine cervix, vulva, and head-neck region (including microinvasive and invasive carcinomas) who are capable of understanding and willing to sign the informed consent form. Prospective patients must provide written informed consent before any procedures.
Exclusion criteria
- Patients presenting any of the following criteria are not eligible for inclusion in this study. Exclusion criteria include:
- Metastatic neoplasia
- Treatment for other oncological pathologies
- Congenital or acquired immunosuppression (HIV, organ transplant, pharmacological)
Where it is running
4 locations listed.
- Istituto Tumori IRCCS Giovanni Paolo II di Bari - Bari, Bari, Italy
- Istituto Nazionale Tumori | "Fondazione Pascale" - Naples, Napoli, Italy
- Università del Piemonte orientale - Novara, Novara, Italy
- Azienda Ospedaliera Universitaria Pisana - Pisa, Pisa, Italy